Grab the Popcorn 🍿
Globalist, Big Pharma drug makers pushing drugs on American 🇺🇸 citizens, using Obama quotes
‘Skinny guy with a weird last name’
His company
His Fellowship
Roivant Sciences Announces Change to its Board of Directors
February 21, 2023 at 8:33 PM EST
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) – Roivant Sciences (Nasdaq: ROIV) today announced that its founder Vivek Ramaswamy has stepped down from the company’s board of directors to focus on his U.S. presidential campaign.
Vivek founded Roivant in 2014 with the vision of revolutionizing drug development. Over the past decade, the FDA has granted six FDA approvals for medicines developed at Vants launched by Roivant, including VTAMA, approved for plaque psoriasis in 2022.
In January 2021, Vivek transitioned out of his day-to-day role as CEO of the company. He served as Roivant’s Chairman until February 20, 2023.
“On behalf of the entire company, I would like to extend our deepest gratitude to Vivek for his vision and leadership over the years. Vivek started Roivant in 2014 to transform the way that meaningful therapies were developed and commercialized, and that mission is still very much a part of Roivant’s DNA today. We are grateful for Vivek’s contributions to the board and to the organization, and we wish him well in his future endeavors,” said Matt Gline, CEO of Roivant.
https://investor.roivant.com/news-releases/news-release-details/roivant-sciences-announces-change-its-board-directors/